Androgenic alopecia

Androgenetic alopecia is the most common form of hair loss and is genetically determined: hair follicles inherit sensitivity to androgens, which shortens their growth phase. It's not a disease, but rather a genetic predisposition. It affects both men and women, typically starting around ages 30-40, though it can begin earlier. Stress, poor nutrition, or hormonal changes may accelerate its progression.

At Santé, we combine three pillars: scalp PRP (platelet-rich plasma that reactivates follicles), scalp mesotherapy with vitamins and growth factors, and medical hair treatment following initial assessment. The protocol is personalized based on alopecia severity and patient characteristics. Combining techniques enhances results by stimulating microcirculation and follicular regeneration.

The typical protocol consists of 4-6 monthly sessions initially, followed by maintenance sessions every 2-3 months. First changes (reduced shedding, stronger hair) appear between sessions 2-3. Significant results in volume and density emerge around months 3-4. Consistency is key: androgenetic alopecia requires ongoing treatment.

It doesn't hurt: PRP and mesotherapy are applied using painless techniques. No downtime or changes to your hair routine are required. You can wash and style normally. Contraindications are minimal (active scalp infections, certain medications). Pre-treatment assessment is mandatory to rule out underlying medical causes and adjust the protocol accordingly.